StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) income statement

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3083% above fair value
$13.09−0.36 (-2.68%)

Close on Nov 20, 2026Market cap $459.03MP/E –Yield –

See a number that looks wrong?